|
|
||||||||
1 Division of Exercise Science, University of Mississippi, University, Mississippi 38677; 2 Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232; and 3 Department of Clinical Physiology and 4 Sports Medicine Research Unit, Bispebjerg Hospital, DK-2400 Copenhagen, Denmark
To determine the
importance of basal glucagon to the stimulation of net splanchnic
glucose output (NSGO) during exercise, seven healthy males performed
cycle exercise during a pancreatic islet cell clamp. In one group (BG),
glucagon was replaced at basal levels and insulin was adjusted to
achieve euglycemia. In another group (GD), only insulin was replaced at
the identical rate used in BG, and basal glucagon was not replaced.
Exogenous glucose infusion was necessary to maintain euglycemia during
exercise in BG and during rest and exercise in GD. Arterial glucagon
was at least twofold greater in BG than in GD throughout the pancreatic islet cell clamp. Although basal NSGO remained stable in BG (2.5 ± 0.5 mg · kg
1 · min
1),
basal NSGO dropped by 70% in GD (0.7 ± 0.3 mg · kg
1 · min
1). NSGO was
also greater in BG than in GD at 10 min of moderate exercise, most
likely due to the residual effect of basal glucagon replacement.
However, NSGO increased slightly and remained similar throughout the
remainder of moderate and heavy exercise in BG and GD. Therefore, a
mechanism independent of changes in pancreatic hormones and/or the
level of glycemia contributes toward modest stimulation of NSGO during
moderate and heavy exercise.
islet cell clamp; hormone replacement
This article has been cited by other articles:
![]() |
S. Banzet, N. Koulmann, N. Simler, H. Sanchez, R. Chapot, B. Serrurier, A. Peinnequin, and X. Bigard Control of gluconeogenic genes during intense/prolonged exercise: hormone-independent effect of muscle-derived IL-6 on hepatic tissue and PEPCK mRNA J Appl Physiol, December 1, 2009; 107(6): 1830 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Febbraio, N. Hiscock, M. Sacchetti, C. P. Fischer, and B. K. Pedersen Interleukin-6 Is a Novel Factor Mediating Glucose Homeostasis During Skeletal Muscle Contraction Diabetes, July 1, 2004; 53(7): 1643 - 1648. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. FEBBRAIO and B. K. PEDERSEN Muscle-derived interleukin-6: mechanisms for activation and possible biological roles FASEB J, September 1, 2002; 16(11): 1335 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Steensberg, M. A Febbraio, T. Osada, P. Schjerling, G. van Hall, B. Saltin, and B. K. Pedersen Interleukin-6 production in contracting human skeletal muscle is influenced by pre-exercise muscle glycogen content J. Physiol., December 1, 2001; 537(2): 633 - 639. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |